Dermatology Doctors in Wichita Falls, TX Accepting Medicare

6 Dermatology doctors found. Showing 1 - 6

Linda A Reinhardt, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 2601 Harrison St, Ste 500, Wichita Falls, TX 76308 Phone: 940-322-9606    Fax: 940-322-9241

Robert T Garbacz, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5 Eureka Cir Ste D, Wichita Falls, TX 76308 Phone: 940-767-3376    Fax: 940-767-1013

Bruce Fleming Mcdonald, DO Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4206 Call Field Rd, Wichita Falls, TX 76308 Phone: 940-397-5200

Mamad Mirza Bagheri, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4327 Barnett Rd, Wichita Falls, TX 76310 Phone: 940-687-3376    Fax: 940-687-3377

Sarah Minka, DO Dermatology Medicare: Medicare Enrolled Practice Location: 4327 Barnett Rd, Wichita Falls, TX 76310 Phone: 940-687-3376    Fax: 940-301-3923

Dr. Erez Abraham Minka, D.O. Dermatology Medicare: Medicare Enrolled Practice Location: 4327 Barnett Rd, Wichita Falls, TX 76310 Phone: 940-687-3376

News Archive

Telaprevir effective in HCV patients

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that data from recent clinical trials suggest that Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir is efficacious in hepatitis C virus patients who have not responded to previous treatment with peg-IFN/ribavirin. In contrast, the efficacy of Merck's (formerly Schering-Plough) boceprevir in treatment nonresponders has yet to be proven.

K-V Pharmaceutical provides update on FDA review of NDA for Gestiva

K-V Pharmaceutical Company today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s New Drug Application for Gestiva as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Soligenix, Inc., a late-stage biotechnology company, announced today the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability. The article was authored by the Company's collaborators at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) where the vaccine originated. RiVax™ is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as non-human primate trials for efficacy.

Exercise helps people to quit smoking, shows new study

Exercise can help smokers quit because it makes cigarettes less attractive. A new study from the University of Exeter shows for the first time that exercise can lessen the power of cigarettes and smoking-related images to grab the attention of smokers. The study is published in the journal Addiction.

Read more Medical News

› Verified 4 days ago